COMMUNIQUÉS West-GlobeNewswire

Herantis Pharma's Manager's Transactions

10/11/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Nine-month interim report (Q3) 2017

10/11/2017 - 07:30

Copenhagen, 2017-11-10 07:30 CET (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2016 are shown in brackets. Revenue growth is measured in local currencies. 2016 comparative figures [...]

MediciNova Appoints Hideki Nagao to its Board of Directors

10/11/2017 - 07:30

LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

10/11/2017 - 07:02

REGULATED INFORMATION GHENT, Belgium, 10 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Sarepta Therapeutics Announces Exercise of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes Due 2024

10/11/2017 - 03:45

CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

MediciNova Announces Collaboration with the U.S. Department of Veterans Affairs and Oregon Health & Science University to Evaluate MN-166 (ibudilast) in Methamphetamine Use Disorder

10/11/2017 - 00:00

LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Sucampo to Host 2017 R&D Day on November 16 in New York

09/11/2017 - 23:48

ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP ), a global biopharmaceutical company, today announced that it will host its 2017 R&D Day for the investment [...]

Dermira to Present at Upcoming Investor Conferences in November

09/11/2017 - 23:36

MENLO PARK, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Myriad Genetics to Present at the 2017 Jefferies London Healthcare Conference

09/11/2017 - 23:30

SALT LAKE CITY, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]

American Health Council Calls for Support to Prevent Closure of Children’s Psychiatric Center

09/11/2017 - 23:24

NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Currently on the state’s closure list, the Western New York Children’s Psychiatric Center (WNYCPC) is facing a possible shutdown with plans for absorption by the Buffalo [...]

Immunovaccine Announces Third Quarter 2017 Financial Results

09/11/2017 - 23:05

HALIFAX, Nova Scotia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today released its financial and operational results for the third quarter [...]

Extendicare Announces 2017 Third Quarter Results

09/11/2017 - 23:00

MARKHAM, Ontario, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today reported results for the three and nine months ended September 30, 2017. Results are presented in [...]

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017

09/11/2017 - 22:59

NORTHVALE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products [...]

Argos Reports Third Quarter 2017 Financial Results and Operational Highlights

09/11/2017 - 22:46

DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]

Forward Pharma to Participate in the Nordic-American Life Science Conference

09/11/2017 - 22:30

COPENHAGEN, Denmark, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ: FWP ) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will participate in the Nordic- [...]

PLx Pharma Inc. Reports Third Quarter 2017 Results

09/11/2017 - 22:30

HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP ) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected products, Aspertec™ 325 [...]

Aptevo Therapeutics Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:30

Strengthened Cash Position to Support Ongoing R&D and Commercial Activities; Reported $107 Million in Cash at the End of the Third Quarter Expanded Novel Bispecific Antibody Portfolio Through Collaboration with [...]

Dyadic International Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:30

JUPITER, Fla., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Galena Biopharma Reports Third Quarter 2017 Financial Results

09/11/2017 - 22:30

SAN RAMON, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today reported [...]